Published in TB and Outbreaks Week, November 12th, 2002
The research will be conducted at the Southwest Foundation for Biomedical Research.
The study, to be done in rats, will be conducted in two phases and will compare the antibody to anthrax toxin developed by UT Austin with an antianthrax antibody screened and selected by EluSys. Both antibodies will be inserted into heteropolymers developed by EluSys.
First, investigators will examine and compare how long heteropolymers containing the UT Austin antibodies and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.